X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world

[1]  H. Ochs,et al.  The co‐occurrence of Wilson disease and X‐linked agammaglobulinemia in one family highlights the promising diagnostic potential of proteolytic analysis , 2020, Molecular genetics & genomic medicine.

[2]  N. Radwan,et al.  Newborn Screening for Primary Immunodeficiencies: The Gaps, Challenges, and Outlook for Developing Countries , 2020, Frontiers in Immunology.

[3]  R. Fuleihan,et al.  Pulmonary Disease Burden in Primary Immune Deficiency Disorders: Data from USIDNET Registry , 2020, Journal of Clinical Immunology.

[4]  J. Zwerina,et al.  Novel Developments in Primary Immunodeficiencies (PID)—a Rheumatological Perspective , 2019, Current Rheumatology Reports.

[5]  A. Fischer,et al.  Intestinal dysbiosis in inflammatory bowel disease associated with primary immunodeficiency. , 2019, The Journal of allergy and clinical immunology.

[6]  A. Condino-Neto,et al.  Changing the Lives of People With Primary Immunodeficiencies (PI) With Early Testing and Diagnosis , 2018, Front. Immunol..

[7]  Mathieu Almeida,et al.  Microbial ecology perturbation in human IgA deficiency , 2018, Science Translational Medicine.

[8]  A. Aghamohammadi,et al.  Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency , 2017, Central-European journal of immunology.

[9]  A. Weber,et al.  Bruton’s Tyrosine Kinase: An Emerging Key Player in Innate Immunity , 2017, Front. Immunol..

[10]  Y. Lau,et al.  Homozygous transcription factor 3 gene (TCF3) mutation is associated with severe hypogammaglobulinemia and B-cell acute lymphoblastic leukemia. , 2017, The Journal of allergy and clinical immunology.

[11]  Hoda Mirsafian,et al.  Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency , 2017, Scientific Reports.

[12]  I. Quinti,et al.  The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement , 2017, PloS one.

[13]  A. Rawat,et al.  Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children , 2017, Journal of Clinical Immunology.

[14]  Ivan K. Chinn,et al.  Update on the use of immunoglobulin in human disease: A review of evidence , 2017, The Journal of allergy and clinical immunology.

[15]  K. Sullivan,et al.  Enteroviruses in X-Linked Agammaglobulinemia: Update on Epidemiology and Therapy. , 2016, The journal of allergy and clinical immunology. In practice.

[16]  O. Ohara,et al.  X-linked agammaglobulinemia: Twenty years of single-center experience from North West India. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[17]  Yi-dan Zhang,et al.  Clinical characteristics and genetic profiles of 174 patients with X-linked agammaglobulinemia , 2016, Medicine.

[18]  J. Kierkuś,et al.  Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinemia in children – 34-year experience of a single center , 2016, Archives of medical science : AMS.

[19]  L. Santos‐Argumedo,et al.  Clinical and mutational features of X-linked agammaglobulinemia in Mexico. , 2016, Clinical immunology.

[20]  L. Jeddane,et al.  X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations , 2016, Journal of Clinical Immunology.

[21]  Y. Lau,et al.  Prevalence of BTK mutations in male Algerian patterns with agammaglobulinemia and severe B cell lymphopenia. , 2015, Clinical immunology.

[22]  S. Spector,et al.  Practice parameter for the diagnosis and management of primary immunodeficiency. , 2015, The Journal of allergy and clinical immunology.

[23]  Laura Marqués,et al.  Agammaglobulinemia ligada al cromosoma X: experiencia en un hospital portugués , 2015 .

[24]  C. Cunningham-Rundles,et al.  An update on the use of immunoglobulin for the treatment of immunodeficiency disorders. , 2014, Immunotherapy.

[25]  C. Cunningham-Rundles,et al.  Autoimmunity and Inflammation in X-linked Agammaglobulinemia , 2014, Journal of Clinical Immunology.

[26]  J. Franco,et al.  Attending to Warning Signs of Primary Immunodeficiency Diseases Across the Range of Clinical Practice , 2013, Journal of Clinical Immunology.

[27]  J. Casanova,et al.  A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(-) B cells. , 2013, The Journal of clinical investigation.

[28]  C. Pignata,et al.  Anti-infective prophylaxis for primary immunodeficiencies: what is done in Italian Primary Immunodeficiency Network centers (IPINet) and review of the literature. , 2013, Journal of biological regulators and homeostatic agents.

[29]  C. Cancrini,et al.  Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia , 2013, Case reports in pediatrics.

[30]  Y. Lau,et al.  Tyrosine Kinase Btk Is Required for NK Cell Activation , 2012, The Journal of Biological Chemistry.

[31]  P. Zhang,et al.  Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk , 2011, Nature Immunology.

[32]  J. Orange,et al.  Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies. , 2010, Clinical Immunology.

[33]  S. Akira,et al.  Augmented TLR9-induced Btk activation in PIR-B–deficient B-1 cells provokes excessive autoantibody production and autoimmunity , 2009, The Journal of experimental medicine.

[34]  A. Plebani,et al.  The Quality of Life of Children and Adolescents with X-Linked Agammaglobulinemia , 2009, Journal of Clinical Immunology.

[35]  D. Campana,et al.  Primary B cell immunodeficiencies: comparisons and contrasts. , 2009, Annual review of immunology.

[36]  P. Newacheck,et al.  Planning for Health Care Transitions: Results From the 2005–2006 National Survey of Children With Special Health Care Needs , 2009, Pediatrics.

[37]  Z. Jacobs,et al.  XLA-associated neutropenia treatment: a case report and review of the literature. , 2008, Journal of pediatric hematology/oncology.

[38]  C. Cunningham-Rundles,et al.  Osteoarticular infectious complications in patients with primary immunodeficiencies , 2008, Current opinion in rheumatology.

[39]  J. A. Linton,et al.  Analysis of Clinical Presentations of Bruton Disease: A Review of 20 Years of Accumulated Data from Pediatric Patients at Severance Hospital , 2008, Yonsei medical journal.

[40]  M. Kaplan,et al.  Bruton’s Tyrosine Kinase Is Required for TLR-Induced IL-10 Production1 , 2006, The Journal of Immunology.

[41]  C. Cunningham-Rundles,et al.  X-Linked Agammaglobulinemia: Report on a United States Registry of 201 Patients , 2006, Medicine.

[42]  E. López-Granados,et al.  A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia. , 2005, The Journal of allergy and clinical immunology.

[43]  J. Hagood,et al.  A Course on the Transition to Adult Care of Patients with Childhood-Onset Chronic Illnesses , 2005, Academic medicine : journal of the Association of American Medical Colleges.

[44]  T. Onodera,et al.  A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans. , 2003, The Journal of clinical investigation.

[45]  L. Notarangelo,et al.  Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. , 2002, Clinical immunology.

[46]  J. V. D. van der Meer,et al.  Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution. , 2002, The Netherlands journal of medicine.

[47]  H. Kanegane,et al.  Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis. , 2001, The Journal of allergy and clinical immunology.

[48]  A. Stray-Pedersen,et al.  Primary Immunodeficiency Diseases in Norway , 2000, Journal of Clinical Immunology.

[49]  D. Nelson,et al.  Bacteremia and skin/bone infections in two patients with X-linked agammaglobulinemia caused by an unusual organism related to Flexispira/Helicobacter species. , 2000, Clinical immunology.

[50]  A. Plebani,et al.  X-Chromosome Inactivation and Mutation Pattern in the Bruton’s Tyrosine Kinase Gene in Patients with X-linked Agammaglobulinemia , 2000, Molecular medicine.

[51]  A. Fischer,et al.  Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. , 1999, The Journal of pediatrics.

[52]  M. Cooper,et al.  Genetic basis of abnormal B cell development. , 1998, Current opinion in immunology.

[53]  M. Conley,et al.  Mutations in btk in patients with presumed X-linked agammaglobulinemia. , 1998, American journal of human genetics.

[54]  N. M. Florí,et al.  Primary Immunodeficiency Syndrome in Spain: First Report of the National Registry in Children and Adults , 1997, Journal of Clinical Immunology.

[55]  P. Furr,et al.  Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. , 1997, British journal of rheumatology.

[56]  Ornella Parolini,et al.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia , 1993, Cell.

[57]  D. Bentley,et al.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases , 1993, Nature.

[58]  W. Hitzig,et al.  Primary immunodeficiencies in Switzerland: First report of the national registry in adults and children , 1988, Journal of Clinical Immunology.

[59]  R. Thompson,et al.  Primary hypogammaglobulinaemia and arthritis. , 1987, British medical journal.

[60]  J. Winkelstein,et al.  X‐Linked Agammaglobulinemia: An Analysis of 96 Patients , 1985, Medicine.

[61]  P. A. Wallenborn,et al.  Agammaglobulinemia , 1960 .

[62]  R. Amin,et al.  Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment. , 2015, Journal of investigational allergology & clinical immunology.

[63]  P. Moja.  The selection and use of essential medicines: Twentieth report of the WHO Expert Committee 2015 (including 19th WHO Model List of Essential Medicines and 5th WHO Model List of Essential Medicines for Children) , 2015 .

[64]  M Vihinen,et al.  Mutations of the human BTK gene coding for bruton tyrosine kinase in X‐linked agammaglobulinemia , 1999, Human mutation.

[65]  R. Hermaszewski,et al.  Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. , 1993, The Quarterly journal of medicine.

[66]  O. C. Bruton.  Agammaglobulinemia (congenital absence of gamma globulin); report of a case. , 1953, The Medical annals of the District of Columbia.